Serum levels of neurotrophic factors in active toxoplasmic retinochoroiditis

AUTOR(ES)

Cordeiro, Cynthia Azeredo, Vieira, Erica Leandro Marciano, Rocha, Natália Pessoa, Castro, Vinicius Monteiro, Oréfice, Juliana Lambert, Barichello, Tatiana, Costa, Rogerio Alves, Oréfice, Fernando, Young, Lucy, Teixeira, Antonio Lucio

FONTE

Braz J Infect Dis

DATA DE PUBLICAÇÃO

2017-03

RESUMO

Abstract Toxoplasmic retinochoroiditis (TR) is the most common identifiable cause of posterior uveitis in Brazil. Response to treatment and clinical presentation may vary significantly. We assessed serum levels of brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), nerve growth factor (NGF), neurotrophin (NT)-3, and NT-4/5 in patients with active TR, before and after TR treatment. Methods: Twenty patients with active lesion and 15 healthy controls were enrolled in the study. Serum concentration of neurotrophic factors was determined by enzyme-linked immunosorbent assay. Results: BDNF levels were significantly higher in patients before treatment when compared with controls (p = 0.0015). There was no significant difference in pro-BDNF, NGF, GDNF, NT-3, and NT-4/5 levels between TR patients and controls. Treatment did not affect the levels of these factors. Conclusion: BDNF may be released in the context of the active TR inflammatory response.

Documentos Relacionados

• Treatment of active toxoplasmic retino-choroiditis.
• Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis
• Utility of Tissue Culture for Detection of Toxoplasma gondii in Vitreous Humor of Patients Diagnosed with Toxoplasmic Retinochoroiditis
• Risk factors for Toxoplasma gondii infection and development of toxoplasmic retinochoroiditis.
• Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.